Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Management of Steroid-Induced Hyperglycemia

Introduction to Steroid-Induced Hyperglycemia

  • The American College of Endocrinology recommends initiating NPH insulin at 0.3-0.5 units/kg/day given in the morning to match the afternoon peak hyperglycemic effect of glucocorticoids, with dose adjustments proportional to steroid tapering 1, 2

Understanding the Hyperglycemic Pattern

  • Peak hyperglycemia occurs 6-9 hours after morning steroid administration, typically in the afternoon and evening, with glucose levels often normalizing overnight even without treatment 1, 3

Monitoring Protocol

  • The Endocrine Society recommends implementing four-times-daily glucose monitoring (fasting and 2 hours after each meal) rather than relying on fasting glucose alone, which will miss the peak hyperglycemic effect 1, 2
  • Target glucose range: 5-10 mmol/L (90-180 mg/dL) 1, 2

Insulin Therapy Algorithm

  • NPH insulin is the preferred agent because its 4-6 hour peak action aligns with the peak hyperglycemic effect of morning glucocorticoid doses 1
  • Starting dose: 0.3-0.5 units/kg/day given in the morning (or 3 hours after steroid administration) 1, 2, 4
  • Higher doses (40-60% increase) may be needed for patients on high-dose glucocorticoids (e.g., prednisone ≥50 mg), those with higher baseline HbA1c, or pre-existing diabetes 1, 2, 4

Dose Adjustment Strategy

  • As steroids are tapered, insulin doses must be proportionally decreased to prevent hypoglycemia 1, 2, 4
  • Adjust insulin based on blood glucose patterns, focusing on afternoon/evening readings 1, 2

Role of Oral Agents

  • Oral antidiabetic agents alone are insufficient for high-dose steroid therapy 1, 2
  • Metformin can be added as an adjunct in patients with preserved renal and hepatic function, with some evidence it alleviates metabolic effects of steroids 4

Perioperative Management

  • Target glucose: 100-180 mg/dL (5.6-10.0 mmol/L) 1
  • Hold oral glucose-lowering agents on day of surgery 1, 2

Patient Education

  • Provide comprehensive education on glucose monitoring technique and frequency, symptoms of severe hyperglycemia, and emergency threshold 1, 2, 4

Life-Threatening Complication

  • Hyperosmolar hyperglycemic state can develop in very severe cases of steroid-induced hyperglycemia 1, 2, 4

Common Pitfalls to Avoid

  • Using only fasting glucose for monitoring (misses peak hyperglycemic effect) 1
  • Relying solely on sliding-scale correction insulin (associated with poor glycemic control) 1
  • Waiting for fasting hyperglycemia before treating (leads to delayed intervention) 1
  • Not anticipating the diurnal pattern with peak effects in afternoon/evening 1
  • Failing to reduce insulin doses proportionally when steroids are tapered 1

REFERENCES

1

Management of Steroid-Induced Diabetes [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Steroid-Induced Hyperglycemia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Corticosteroid-Induced Hyperglycemia Mechanisms [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025